|
US2011123486A1
|
|
Methods of treating multiple myeloma and resistant cancers
|
|
CN101374819A
|
|
Aryl-substituted quinazolones and uses thereof
|
|
CA2634768A1
|
|
3-aryl-substituted quinazolones, and uses thereof
|
|
TW200811185A
|
|
Fused pyrimidones and thiopyrimidones, and uses thereof
|
|
CN101218211A
|
|
Quinoxaline derivatives as antitumor agents
|
|
CA2595848A1
|
|
Erastin and erastin binding proteins, and uses thereof
|
|
AU2005216969A1
|
|
Non-peptidyl agents with pHSP20-like activity, and uses thereof
|
|
WO2005057208A1
|
|
Methods of identifying peptides and proteins
|
|
US7825227B2
|
|
Method for purification of a protein complex and identification of its components
|
|
AU2003228944A8
|
|
Protein complex purification
|
